title: Cytogenetic studies of ethyl acrylate using C57BL/6 mice.
abstract: The clastogenicity of ethyl acrylate (EA) was examined in vivo by injecting i.p. five male C57BL/6 mice per dose group with either 125, 250, 500 or 1000 mg/kg EA dissolved in saline. Controls received solvent only. Acrylamide (100 mg/kg), because of its similarity in structure and mode of action to EA, was used as a positive control. Twenty-four hours after injection, the animals were anesthetized and the spleens aseptically removed. Splenocytes were isolated on density gradients and cultured with concanavalin A to stimulate cell division. In half the cultures bromodeoxyuridine was added at 21 h for analysis of chromosome aberrations (CAs) in first division cells and sister chromatid exchange (SCE) in second division cells. In the remaining cultures cytochalasin B was added to produce binucleated cells for scoring of micronuclei (MN). There was no significant increase in SCE or CAs at any of the doses of EA examined. At the highest dose examined (1000 mg/kg), EA did cause a small but significant increase in binucleated cell MN. Acrylamide caused an increase in MN and SCEs in splenocytes. Because others have found EA to be clastogenic in vitro, isolated splenocytes were exposed to a wide range of concentrations of EA during the G0 stage of the cell cycle or 23 h after mitogen stimulation during the late G1 or early S phase of the cell cycle. Although EA was toxic for both exposure regimens, significant increases in chromatid-type aberrations were found only when the target cells were treated 23 h after mitogenic stimulation. No statistically significant increase in SCE frequency was found after either treatment regimen. These data suggest that EA is only clastogenic at near toxic concentrations during a specific stage of the cell cycle.
authors.affiliation: US Environmental Protection Agency, Research Triangle Park, NC 27711.
authors.forename: A D
authors.initials: AD
authors.lastname: Kligerman
authors.forename: A L
authors.initials: AL
authors.lastname: Atwater
authors.forename: M F
authors.initials: MF
authors.lastname: Bryant
authors.forename: G L
authors.initials: GL
authors.lastname: Erexson
authors.forename: P
authors.initials: P
authors.lastname: Kwanyuen
authors.forename: K L
authors.initials: KL
authors.lastname: Dearfield
mesh_terms: D020106:Acrylamide; D000178:Acrylamides / Q000633:toxicity; D000179:Acrylates / Q000633:toxicity*; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D015162:Micronucleus Tests; D009152:Mutagenicity Tests; D012854:Sister Chromatid Exchange / Q000187:drug effects*; D013154:Spleen / Q000166:cytology
chemical_list: D000178:Acrylamides; D000179:Acrylates; D020106:Acrylamide; C040833:ethyl acrylate